South & Central America Continuous Ambulatory Peritoneal Dialysis Market Size and Forecast (2021

Description

List of Tables

The South and Central America Continuous Ambulatory Peritoneal Dialysis Market is projected to reach US$ 121.7 Million by 2034, compared with US$ 98.1 Million in 2025. The market is anticipated to expand at a CAGR of 2.4% from 2026 to 2034.

Executive Summary and South and Central America Continuous Ambulatory Peritoneal Dialysis Market Analysis:

The continuous ambulatory peritoneal dialysis (CAPD) market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. Increasing cases of chronic kidney disease (CKD) and end-stage renal disease (ESRD), associated largely with the widespread prevalence of diabetes and hypertension, are generating greater demand for renal replacement therapies across the region.

CAPD is gaining attention because of its relatively straightforward treatment process, lower infrastructure requirements, and suitability for home-based care. Compared with conventional in-center hemodialysis, CAPD can reduce the need for frequent visits to dialysis facilities, making it particularly relevant for patients living in rural or geographically remote areas. Its comparatively lower infrastructure requirements can also benefit healthcare systems operating under financial and resource constraints.

Government healthcare programs and providers are increasingly exploring decentralized and home-based dialysis approaches to expand treatment accessibility while managing healthcare expenditure. Growing patient awareness of CAPD, greater interest in independent treatment, and improvements in dialysis solutions, catheter technologies, and patient education are additional factors supporting adoption. As the regional CKD burden continues to rise, CAPD offers an opportunity to broaden access to renal replacement care while supporting more patient-centered treatment models.

Strategic Insights

South and Central America Continuous Ambulatory Peritoneal Dialysis Market Segmentation Analysis:

By Product Type, the South and Central America Continuous Ambulatory Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others. The Peritoneal Dialysis Solution segment dominated the market in 2025.
By End User, the market is segmented into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings segment held the largest market share in 2025.

Market Report Scope

South and Central America Continuous Ambulatory Peritoneal Dialysis Market Outlook

The CAPD market has considerable development potential in emerging economies where the number of patients with kidney failure is increasing while dialysis infrastructure remains concentrated in major urban centers. Brazil represents a particularly important market because of its large population, significant CKD burden, and extensive geographic area.

Data from the Brazilian Dialysis Survey 2023, published by the Brazilian Society of Nephrology, indicated that approximately 157,357 patients were receiving dialysis treatment in July 2023. Peritoneal dialysis accounted for only a small portion of total dialysis modalities, highlighting the considerable opportunity to increase adoption of home-based PD. The relatively low utilization of PD also suggests that barriers related to healthcare infrastructure, provider availability, patient education, reimbursement, and treatment preferences continue to influence modality selection.

CAPD can provide an attractive alternative in locations where access to dialysis centers is difficult. Because treatment can be performed in the patient's home and does not require repeated sessions at a specialized facility, it can help reduce transportation challenges and improve continuity of care. This is particularly relevant for populations living outside major metropolitan areas.

The high prevalence of diabetes and hypertension continues to contribute to the expansion of the CKD and ESRD patient population. At the same time, limited dialysis capacity and healthcare expenditure pressures are encouraging policymakers to consider treatment models that can deliver care more efficiently.

Greater investment in CAPD education, nephrology training, patient support, and supply-chain infrastructure could help overcome existing adoption barriers. Expanding home dialysis programs through public healthcare systems may also reduce pressure on centralized facilities and improve access for underserved communities.

As governments and healthcare providers focus on sustainable kidney-care strategies, increased use of CAPD could support broader treatment coverage while offering eligible patients greater autonomy. The combination of rising disease prevalence, healthcare modernization, and growing awareness of home dialysis is expected to create additional opportunities for the regional CAPD market.

South and Central America Continuous Ambulatory Peritoneal Dialysis Market Country Insights

By country, the South and Central America Continuous Ambulatory Peritoneal Dialysis Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil held the largest market share in 2025.

Brazil has a substantial CKD and ESRD burden, with diabetes and hypertension serving as important contributors to the increasing need for renal replacement treatment. According to the Brazilian Dialysis Survey 2023, approximately 157,357 people were receiving dialysis in the country as of July 2023. Hemodialysis remained the dominant modality, while peritoneal dialysis, including CAPD, represented a considerably smaller share.

Brazil's public healthcare system plays a major role in providing dialysis services. The country's long-standing focus on CKD prevention has included efforts to improve early diagnosis and management of risk factors through primary healthcare. However, the continued increase in patients requiring dialysis highlights the need for additional treatment capacity and alternative modalities.

Recent initiatives have placed greater emphasis on expanding home-based peritoneal dialysis. In 2024, the National Federation of Renal Patients, together with the Brazilian Society of Nephrology, advocated stronger support for home PD programs within the Unified Health System (SUS), increased funding for dialysis centers, and enhanced professional training. Such measures could help improve CAPD availability and encourage greater use of home-based renal replacement therapy.

Strengthening CAPD programs could provide several benefits, including improved access for patients outside major cities, reduced dependence on centralized dialysis facilities, and greater flexibility in treatment schedules. Continued investment in education, reimbursement, clinical infrastructure, and supply availability will be important for overcoming barriers to broader PD adoption.

South and Central America Continuous Ambulatory Peritoneal Dialysis Market Company Profiles

Key companies operating in the market include Terumo Corp, Medtronic Plc, Baxter International Inc, Advin Health Care Pvt Ltd, Fresenius Medical Care AG & Co KGaA, Utah Medical Products Inc, JMS Co Ltd, Polymedicure, Mitra Industries Pvt. Ltd., and Newsol Technologies Inc.

These companies are implementing strategies such as geographic expansion, product innovation, strategic collaborations, and mergers and acquisitions to strengthen their market presence. Their initiatives focus on developing advanced dialysis products, expanding distribution networks, improving treatment solutions, and addressing the increasing demand for accessible and patient-centered CAPD services across South and Central America.

Product Code: TIPRE00044039

1. Executive Summary

1.1 Analyst Market Outlook

2. Global Continuous Ambulatory Peritoneal Dialysis Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Continuous Ambulatory Peritoneal Dialysis Market - South and Central America Analysis

5.1 South and Central America Continuous Ambulatory Peritoneal Dialysis Market Revenue (US$ Million), 2021 - 2034
5.2 South and Central America Continuous Ambulatory Peritoneal Dialysis Market Revenue Forecast and Analysis

6. South and Central America Continuous Ambulatory Peritoneal Dialysis Market Revenue Analysis - by Product Type

6.1 South and Central America Continuous Ambulatory Peritoneal Dialysis Market Forecast and Analysis by Product Type
- 6.1.1 Peritoneal Dialysis Solution
  - 6.1.1.1 Overview
  - 6.1.1.2 Peritoneal Dialysis Solution: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.2 Peritoneal Dialysis Catheters
  - 6.1.2.1 Overview
  - 6.1.2.2 Peritoneal Dialysis Catheters: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.3 Peritoneal Dialysis Transfer Sets
  - 6.1.3.1 Overview
  - 6.1.3.2 Peritoneal Dialysis Transfer Sets: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.4 Others
  - 6.1.4.1 Overview
  - 6.1.4.2 Others: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

7. South and Central America Continuous Ambulatory Peritoneal Dialysis Market Revenue Analysis - by End User

7.1 South and Central America Continuous Ambulatory Peritoneal Dialysis Market Forecast and Analysis by End User
- 7.1.1 In-Center Dialysis Settings
  - 7.1.1.1 Overview
  - 7.1.1.2 In-Center Dialysis Settings: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.2 Home Care Settings
  - 7.1.2.1 Overview
  - 7.1.2.2 Home Care Settings: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

8. South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Country Analysis

8.1 South and Central America
- 8.1.1 South and Central America Continuous Ambulatory Peritoneal Dialysis Market Forecast and Analysis - by Country
  - 8.1.1.1 Brazil Market
    - 8.1.1.1.1 Brazil: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.1.2 Brazil: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.1.2.1 Product Type
      - 8.1.1.1.2.2 End User
  - 8.1.1.2 Argentina Market
    - 8.1.1.2.1 Argentina: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.2.2 Argentina: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.2.2.1 Product Type
      - 8.1.1.2.2.2 End User
  - 8.1.1.3 Rest of South and Central America Market
    - 8.1.1.3.1 Rest of South and Central America: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 8.1.1.3.2 Rest of South and Central America: South and Central America Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
      - 8.1.1.3.2.1 Product Type
      - 8.1.1.3.2.2 End User

9 Continuous Ambulatory Peritoneal Dialysis Market Industry Landscape

10 - Key Company Profiles

10.1 Terumo Corp
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Medtronic Plc
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Baxter International Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Advin Health Care Pvt Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Fresenius Medical Care AG & Co KGaA
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Utah Medical Products Inc
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 JMS Co Ltd
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Polymedicure
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Mitra Industries Pvt. Ltd.
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Newsol Technologies Inc.
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 Glossary
11.4 Research Methodology and Approach
- 11.4.1 Secondary Research
- 11.4.2 Primary Research
- 11.4.3 Market Estimation Approach
  - 11.4.3.1 Supply Side Analysis
  - 11.4.3.2 Demand Side Analysis
- 11.4.4 Research Assumptions and Limitations
- 11.4.5 Currency Conversion
11.5 About The Insight Partners
11.6 Market Intelligence Cloud